About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK

NCT04405232·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Dr Deepa Jayakody Arachchillage, MRCP, FRCPath, MD
CONTACT
02073518401 d.arachchillage@imperial.ac.uk

Lead

Imperial College London

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adult patients (\>18 years) admitted hospitals with COVID 19 infection (COVID RNA+ +/- radiological change +/- clinical suspicion in absence of RNA)

You may not be if

No exclusions

The record

StatusUnknown

PhaseNo phase

Taking part5,000

StartedMay 2020

UpdatedJul 31, 2020

Conditions

COVID Thrombosis Bleeding Anticoagulation

Where1

Imperial College Healthcare NHS Trust
London, United Kingdom

Clareo Health | Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK